Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-30T20:07:56.207Z Has data issue: false hasContentIssue false

Enterococcal Bacteremia in Cancer Patients

Published online by Cambridge University Press:  02 January 2015

E. Bilíková
Affiliation:
University of TrnavaBratislava, Slovakia
J. Hanzen
Affiliation:
University of TrnavaBratislava, Slovakia
I. Svetlansky
Affiliation:
University of TrnavaBratislava, Slovakia
M. Lisková
Affiliation:
University of TrnavaBratislava, Slovakia
A. Roidová
Affiliation:
University of TrnavaBratislava, Slovakia
V. Krcméry
Affiliation:
University of TrnavaBratislava, Slovakia
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2001

References

1.Goosen, SH. Clinical epidemiology of glycopeptide-resistant enterococci in Europe. In: Brun-Buisson, C, Eliopoulos, G, Leclerq, R, eds. Bacterial Resistance to Glycopeptides. Flammarion, Paris, France: Medicine Sciences; 1998.Google Scholar
2.Edmond, MB, Ober, JF, Weinbaum, DL, Pfaller, MA, Hwang, TG, Sanford, MD. Vancomycin resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:11261133.CrossRefGoogle ScholarPubMed
3.Garbutt, JM, Veertrapragda, M, Littenberg, B, Mundy, L. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis 2000;30:466472.CrossRefGoogle ScholarPubMed